As FSH upregulates inhibin B and anti-Müllerian hormone (AMH) synthesis by Sertoli cells, these serve as crucial biomarkers for diagnosing CHH and monitoring the therapeutic response to gonadotropin treatment for the induction of puberty and spermatogenesis (Rohayem et al., 2015). Here, BRD2 is linked to cartilage-hair hypoplasia.